Robert D. Titus

Attorney at Law

Robert D. Titus
Attorney at Law

Bob’s practice is focused on intellectual property investigations, portfolio management, trade secrets, and international patent procurement. As in-house counsel at Eli Lilly Company and Elanco for 24 years, Bob has extensive experience in international patent procurement, portfolio management, client counseling, due diligence investigations, freedom-to-operate analysis, and IP license agreement negotiations in the human and animal health industries.

Due to his deep expertise in small molecule structural obviousness determinations, Bob has served as of counsel in US and foreign patent litigation matters including defense of patent rights covering the antipsychotic olanzapine and its use for the treatment of schizophrenia. He also served as a corporate representative to the Protect Trade Secrets Coalition that was instrumental in the 2016 passage of the Federal Defend Trade Secrets Act.

Bob has been actively involved with the Chemical Practice and Trade Secret Committees of the American Intellectual Property Law Association. He has taught collegiate classes in general and organic chemistry, and high school chemistry and physics. Bob also volunteers his time as pro bono counsel to nonprofit organizations and small businesses.

Prior to becoming an attorney, Bob had a successful career as a process chemist for Warner Lambert and a research chemist for Eli Lilly and Company. His research resulted in the grant of 20 patents encompassing novel molecules and synthetic processes.

Admissions

  • Licensed to practice in Indiana
  • Registered Patent Attorney – United States Patent Office
  • Member of the United States Court of Appeals Seventh and Federal Circuits
  • Member of the Southern District Court of Indiana

Education

  • Juris Doctorate, Indiana University School of Law – Indianapolis
  • Master of Science, Indiana University – Purdue University at Indianapolis
  • Bachelor of Arts, Chemistry, Hope College

Publications, Speeches and Presentations

  • STRANGLEHOLD!  Written Description and Functional Claiming in the Chemical and Biotech Arts, American Intellectual Property Law Association Webinar, January 7, 2016
  • Functional Claim Elements in the Unpredictable Arts, American Intellectual Property Law Association Spring Meeting, May 1, 2015
  • America Invents Act:  Practical Considerations for Practitioners and Inventors, American Bar Association Annual Meeting, Chicago, August 2012
  • Restriction of Markush Claims:  Theory and Reality, American Intellectual Property Law Association Chemical Practice Committee Webinar, April 3, 2012
Menu